REQUEST A DEMO
Total
USD $0.00
Search more companies

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (Hong Kong) (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Navigational, Measuring, Electromedical, and Control Instruments Manufacturing | Management of Companies and Enterprises
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Profile Updated: September 02, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English & Chinese Download a sample report

Principally engaged in the manufacture of Chinese Patent Medicine (“CPM”), the wholesale, retail, import and export of western pharmaceutical products, CPM and medical apparatus and the wholesale, retail of Chinese raw medicine.

Headquarters
Room 2005, 20th Floor, Tower II, Lippo Tower, 89 Queensway, Hong Kong
Hong Kong; Hong Kong;

Contact Details: Purchase the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (Hong Kong) report to view the information.

Website: http://www.gybys.com.cn

Basic Information
Total Employees:
Purchase the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (Hong Kong) report to view the information.
Outstanding Shares:
Purchase the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (Hong Kong) report to view the information.
Registered Capital:
Purchase the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (Hong Kong) report to view the information.
Financial Auditors:
Purchase the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (Hong Kong) report to view the information.
Ratings:
Purchase the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (Hong Kong) report to view the information.
Incorporation Date:
September 01, 1997
Key Executives
Purchase this report to view the information.
Chairman and Executive Director
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Independent Non-Exec Director
Purchase this report to view the information.
Independent Non-Exec Director
Ownership Details
Purchase this report to view the information.
45.04%
Subsidiaries
Baiyunshan Medical and Healthcare Industry Company (China)
100%
Baiyunshan Weiling Pharmaceutical Co., Ltd. ('WeiLing') (China)
100%
Gansu Guangyao Baiyunshan Traditional Chinese Medicine Technology Co., Ltd. (China)
100%
Company Performance
Financial values in the chart are available after Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (Hong Kong) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
18.57%
Total operating revenue
18.57%
Operating profit (EBIT)
27.21%
EBITDA
23.91%
Net Profit (Loss) for the Period
40.55%
Total assets
13.6%
Total equity
11.36%
Operating Profit Margin (ROS)
0.57%
Net Profit Margin
1.14%
Return on Equity (ROE)
1.83%
Debt to Equity Ratio
6.49%
Quick Ratio
0.06%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?